Table 3.
Clinical parameters of the patients.
Non-CAD | CAD | p Value | |
---|---|---|---|
SBP (mmHg) | 122 ± 18 | 126 ± 24 | 0.581 |
DBP (mmHg) | 70 ± 14 | 72 ± 17 | 0.804 |
EF (%) | 63 ± 6 | 56 ± 15 | 0.054 |
E/A | 0.83 ± 0.46 | 1.18 ± 0.76 | 0.148 |
E/E’ | 17.49 ± 9.71 | 14.17 ± 8.60 | 0.387 |
BNP (pg/mL) | 289 ± 732 | 648 ± 1381 | 0.328 |
WBC (102/µL) | 50 ± 17 | 61 ± 15 | 0.057 |
RBC (104/µL) | 333 ± 42 | 377 ± 50 | 0.011 |
Plt (104/µL) | 17.7 ± 12.3 | 21.2 ± 4.8 | 0.332 |
Hb (g/dL) | 10.2 ± 1.7 | 11.3 ± 1.8 | 0.079 |
Ht (%) | 30.6 ± 4.6 | 33.7 ± 4.7 | 0.073 |
TG (mg/dL) | 114 ± 86 | 108 ± 37 | 0.807 |
LDL-C (mg/dL) | 88 ± 30 | 72 ± 20 | 0.111 |
HDL-C (mg/dL) | 47 ± 14 | 41 ± 10 | 0.153 |
PPG (mg/dL) | 120 ± 25 | 139 ± 26 | 0.041 |
HbA1c (NGSP %) | 5.6 ± 0.7 | 6.6 ± 1.4 | 0.010 |
Insulin (µU/mL) | 12.1 ± 11.5 | 10.9 ± 5.4 | 0.728 |
TP (g/dL) | 6 ± 0.9 | 6.5 ± 0.8 | 0.092 |
Alb (g/dL) | 3.2 ± 0.5 | 3.3 ± 0.6 | 0.413 |
AST (U/L) | 20 ± 13 | 17 ± 8 | 0.447 |
ALT (U/L) | 21 ± 35 | 17 ± 14 | 0.715 |
eGFR (mL/min) | 53 ± 24 | 60 ± 25 | 0.425 |
CRP (mg/dL) | 0.37 ± 0.86 | 1.53 ± 4.48 | 0.253 |
Data are presented as means ± SD or number (%) of patients as indicated. p values were determined by Student t-test, with those less than 0.05 being highlighted in bold. CAD: coronary artery disease, SBP: systolic blood pressure, DBP: diastolic blood pressure, EF: ejection fraction, E/A: the ratio of early filling (E) and atrial contraction (A) transmitral flow velocities, E/E’: the ratio of early diastolic mitral inflow velocity to early diastolic mitral annular velocity, BNP: brain natriuretic peptide, WBC: white blood cell count, RBC: red blood cell count, PLT: platelet count, Hb: hemoglobin, Ht: hematocrit, TG: triglyceride, LDL-C: low-density lipoprotein cholesterol, HDL-C: high-density lipoprotein cholesterol, PPG: postprandial glucose, TP: total protein, Alb: albumin, AST: aspartate aminotransferase, ALT: alanine aminotransferase, eGFR: estimated glomerular filtration rate, CRP: C-reactive protein.